Literature DB >> 23836559

Genetic interaction between Kit and Scl.

Julie Lacombe1, Gorazd Krosl, Mathieu Tremblay, Bastien Gerby, Richard Martin, Peter D Aplan, Sebastien Lemieux, Trang Hoang.   

Abstract

SCL/TAL1, a tissue-specific transcription factor of the basic helix-loop-helix family, and c-Kit, a tyrosine kinase receptor, control hematopoietic stem cell survival and quiescence. Here we report that SCL levels are limiting for the clonal expansion of Kit⁺ multipotent and erythroid progenitors. In addition, increased SCL expression specifically enhances the sensitivity of these progenitors to steel factor (KIT ligand) without affecting interleukin-3 response, whereas a DNA-binding mutant antagonizes KIT function and induces apoptosis in progenitors. Furthermore, a twofold increase in SCL levels in mice bearing a hypomorphic Kit allele (W41/41) corrects their hematocrits and deficiencies in erythroid progenitor numbers. At the molecular level, we found that SCL and c-Kit signaling control a common gene expression signature, of which 19 genes are associated with apoptosis. Half of those were decreased in purified megakaryocyte/erythroid progenitors (MEPs) from W41/41 mice and rescued by the SCL transgene. We conclude that Scl operates downstream of Kit to support the survival of MEPs. Finally, higher SCL expression upregulates Kit in normal bone marrow cells and increases chimerism after bone marrow transplantation, indicating that Scl is also upstream of Kit. We conclude that Scl and Kit establish a positive feedback loop in multipotent and MEPs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23836559      PMCID: PMC3952531          DOI: 10.1182/blood-2011-01-331819

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  55 in total

1.  EBF proteins participate in transcriptional regulation of Xenopus muscle development.

Authors:  Yangsook Song Green; Monica L Vetter
Journal:  Dev Biol       Date:  2011-08-04       Impact factor: 3.582

2.  Identification of a ligand for the c-kit proto-oncogene.

Authors:  D E Williams; J Eisenman; A Baird; C Rauch; K Van Ness; C J March; L S Park; U Martin; D Y Mochizuki; H S Boswell
Journal:  Cell       Date:  1990-10-05       Impact factor: 41.582

3.  An scl gene product lacking the transactivation domain induces bony abnormalities and cooperates with LMO1 to generate T-cell malignancies in transgenic mice.

Authors:  P D Aplan; C A Jones; D S Chervinsky; X Zhao; M Ellsworth; C Wu; E A McGuire; K W Gross
Journal:  EMBO J       Date:  1997-05-01       Impact factor: 11.598

4.  Simple rules for complex processes: new lessons from the budding yeast cell cycle.

Authors:  James E Ferrell
Journal:  Mol Cell       Date:  2011-08-19       Impact factor: 17.970

5.  C/EBPepsilon directly interacts with the DNA binding domain of c-myb and cooperatively activates transcription of myeloid promoters.

Authors:  W Verbeek; A F Gombart; A M Chumakov; C Müller; A D Friedman; H P Koeffler
Journal:  Blood       Date:  1999-05-15       Impact factor: 22.113

6.  The TAL1/SCL transcription factor regulates cell cycle progression and proliferation in differentiating murine bone marrow monocyte precursors.

Authors:  Soumyadeep Dey; David J Curtis; Stephen M Jane; Stephen J Brandt
Journal:  Mol Cell Biol       Date:  2010-03-01       Impact factor: 4.272

7.  Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells.

Authors:  C L Miller; V I Rebel; M E Lemieux; C D Helgason; P M Lansdorp; C J Eaves
Journal:  Exp Hematol       Date:  1996-02       Impact factor: 3.084

8.  The SCL relative LYL-1 is required for fetal and adult hematopoietic stem cell function and B-cell differentiation.

Authors:  Claude Capron; Yann Lécluse; Anna Lila Kaushik; Adlen Foudi; Catherine Lacout; Dalila Sekkai; Isabelle Godin; Olivier Albagli; Isabelle Poullion; Fedor Svinartchouk; Elisabeth Schanze; William Vainchenker; Fred Sablitzky; Annelise Bennaceur-Griscelli; Dominique Duménil
Journal:  Blood       Date:  2006-03-02       Impact factor: 22.113

9.  Kit regulates maintenance of quiescent hematopoietic stem cells.

Authors:  Lina A Thorén; Karina Liuba; David Bryder; Jens M Nygren; Christina T Jensen; Hong Qian; Jennifer Antonchuk; Sten-Eirik W Jacobsen
Journal:  J Immunol       Date:  2008-02-15       Impact factor: 5.422

10.  Loss of TAL-1 protein activity induces premature apoptosis of Jurkat leukemic T cells upon medium depletion.

Authors:  K Leroy-Viard; M A Vinit; N Lecointe; H Jouault; U Hibner; P H Roméo; D Mathieu-Mahul
Journal:  EMBO J       Date:  1995-05-15       Impact factor: 11.598

View more
  11 in total

Review 1.  Hematopoietic stem and progenitor cell signaling in the niche.

Authors:  Stephanie N Hurwitz; Seul K Jung; Peter Kurre
Journal:  Leukemia       Date:  2020-10-19       Impact factor: 11.528

2.  High-throughput screening in niche-based assay identifies compounds to target preleukemic stem cells.

Authors:  Bastien Gerby; Diogo F T Veiga; Jana Krosl; Sami Nourreddine; Julianne Ouellette; André Haman; Geneviève Lavoie; Iman Fares; Mathieu Tremblay; Véronique Litalien; Elizabeth Ottoni; Milena Kosic; Dominique Geoffrion; Joël Ryan; Paul S Maddox; Jalila Chagraoui; Anne Marinier; Josée Hébert; Guy Sauvageau; Benjamin H Kwok; Philippe P Roux; Trang Hoang
Journal:  J Clin Invest       Date:  2016-10-31       Impact factor: 14.808

Review 3.  Emerging EPO and EPO receptor regulators and signal transducers.

Authors:  David Kuhrt; Don M Wojchowski
Journal:  Blood       Date:  2015-04-17       Impact factor: 22.113

4.  SCL, LMO1 and Notch1 reprogram thymocytes into self-renewing cells.

Authors:  Bastien Gerby; Cedric S Tremblay; Mathieu Tremblay; Shanti Rojas-Sutterlin; Sabine Herblot; Josée Hébert; Guy Sauvageau; Sébastien Lemieux; Eric Lécuyer; Diogo F T Veiga; Trang Hoang
Journal:  PLoS Genet       Date:  2014-12-18       Impact factor: 5.917

5.  Evolution of AF6-RAS association and its implications in mixed-lineage leukemia.

Authors:  Matthew J Smith; Elizabeth Ottoni; Noboru Ishiyama; Marilyn Goudreault; André Haman; Claus Meyer; Monika Tucholska; Genevieve Gasmi-Seabrook; Serena Menezes; Rob C Laister; Mark D Minden; Rolf Marschalek; Anne-Claude Gingras; Trang Hoang; Mitsuhiko Ikura
Journal:  Nat Commun       Date:  2017-10-23       Impact factor: 14.919

6.  CD244 maintains the proliferation ability of leukemia initiating cells through SHP-2/p27kip1 signaling.

Authors:  Feifei Zhang; Xiaoye Liu; Chiqi Chen; Jun Zhu; Zhuo Yu; Jingjing Xie; Li Xie; Haitao Bai; Yaping Zhang; Xia Fang; Hao Gu; Chun Wang; Wei Weng; Cheng Cheng Zhang; Guo-Qiang Chen; Aibing Liang; Junke Zheng
Journal:  Haematologica       Date:  2017-01-25       Impact factor: 9.941

7.  GM-CSF Inhibits c-Kit and SCF Expression by Bone Marrow-Derived Dendritic Cells.

Authors:  Amairelys Belen Barroeta Seijas; Sonia Simonetti; Sara Vitale; Daniele Runci; Angela Caterina Quinci; Alessandra Soriani; Mattia Criscuoli; Irene Filippi; Antonella Naldini; Federico Maria Sacchetti; Umberto Tarantino; Francesco Oliva; Eleonora Piccirilli; Angela Santoni; Francesca Di Rosa
Journal:  Front Immunol       Date:  2017-02-16       Impact factor: 7.561

8.  A novel slug-containing negative-feedback loop regulates SCF/c-Kit-mediated hematopoietic stem cell self-renewal.

Authors:  Z Zhang; P Zhu; Y Zhou; Y Sheng; Y Hong; D Xiang; Z Qian; J Mosenson; W-S Wu
Journal:  Leukemia       Date:  2016-07-25       Impact factor: 11.528

9.  The Role of TAL1 in Hematopoiesis and Leukemogenesis.

Authors:  E R Vagapova; P V Spirin; T D Lebedev; V S Prassolov
Journal:  Acta Naturae       Date:  2018 Jan-Mar       Impact factor: 1.845

10.  A single-cell hematopoietic landscape resolves 8 lineage trajectories and defects in Kit mutant mice.

Authors:  Joakim S Dahlin; Fiona K Hamey; Blanca Pijuan-Sala; Mairi Shepherd; Winnie W Y Lau; Sonia Nestorowa; Caleb Weinreb; Samuel Wolock; Rebecca Hannah; Evangelia Diamanti; David G Kent; Berthold Göttgens; Nicola K Wilson
Journal:  Blood       Date:  2018-03-27       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.